These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 7871395)

  • 41. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
    D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
    Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M; Maeda S; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma.
    Visakorpi T
    J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
    Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.
    Frankfurt OS; Greco WR; Slocum HK; Arbuck SG; Gamarra M; Pavelic ZP; Rustum YM
    Cytometry; 1984 Nov; 5(6):629-35. PubMed ID: 6518938
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
    Smaaland R; Lote K; Sothern RB; Laerum OD
    Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
    Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
    Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of PCNA proliferating fraction for prognosis of ovarian carcinoma].
    Schönborn I; Minguillon C; Reles A; Bartel U; Lichtenegger W
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):357-64. PubMed ID: 8964450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of flow-cytometry and immunohistochemistry with proliferating monoclonal antibody. Cell nuclear antigen (PCNA) in the study of proliferative kinetics of renal carcinoma].
    Villari D; Iannelli F; Li Marzi V; Marzocco M; Amorosi A; Trippitelli A; Nicita G
    Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():33-7. PubMed ID: 9181920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
    al-Abadi H; Nagel R
    Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry.
    Jochum W; Schröder S; al-Taha R; August C; Gross AJ; Berger J; Padberg BC
    Cancer; 1996 Feb; 77(3):514-21. PubMed ID: 8630959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
    Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
    Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.